Lv1
18 积分 2024-08-08 加入
Stopping nucleos(t)ide analogues in chronic hepatitis B using HBsAg thresholds: A meta analysis and meta-regression
1天前
已完结
OS-030 efficacy and safety of xal⁃ nesiran with and without an immunomodulator in virologically sup⁃ pressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label plat⁃ form study (PIRANGA)
1天前
已完结
Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients
6个月前
已完结
ETS2 alleviates acute‐on‐chronic liver failure by suppressing excessive inflammation
6个月前
已完结
SPARC inhibition accelerates NAFLD‐associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism
6个月前
已完结
TUBB4B is a novel therapeutic target in non‐alcoholic fatty liver disease‐associated hepatocellular carcinoma
6个月前
已完结
Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway
6个月前
已完结
Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target
6个月前
已完结
Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma
6个月前
已完结
皖公网安备34019202002308
